Book a Meeting

Non-Fucosylated Anti-Human Vasohibin 2 (1760) Therapeutic Antibody (CAT#: BioBet-1417ZP) Datasheet

Target
Vasohibin 2
Isotype
IgG
Description
ADCC-Enhanced anti-Vasohibin 2 (1760) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform.
Indication
Cancer
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Vasohibin 2 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
VASH2
Full Name
vasohibin 2
Alternative Names
VASH2; vasohibin 2; vasohibin-2; vasohibin-like protein
Gene ID
Cellular Localization
Extracellular region or secreted, Cytoskeleton
Involvement in Disease
Diseases associated with VASH2 include Aarskog-Scott Syndrome.
Function
Tyrosine carboxypeptidase removes the c-terminal tyrosine residue of tubulin, thereby regulating microtubule dynamics and function. Spindle function and accurate chromosome segregation during mitosis are critical, because microcellular denucleation regulates the length and position of the mitotic spindle. As an activator of angiogenesis: expressed in the mononuclear cells of the bud front line, promote angiogenesis. Play a role in axon formation.
Field of research
Cell Biology and Cellular Response antibody; Developmental Biology antibody
Post-translational modifications
1.Modification sites at neXtProt 2.Modification sites at PhosphoSitePlus
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
1760
Host
Humanized
Species Reactivity
Human
Description
The anti-vasohibin 2 antibody is capable of recognizing vasohibin 2 protein at a high specificity and inhibiting the neovascularization promoting function of vasohibin 2 protein. Thus, a medicinal composition containing the anti-vasohibin 2 antibody is appropriately usable in, for example, treating diseases, such as cancer, where neovascularization should be inhibited.
Indication
Cancer

Cancer

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany